Respiratory Depression in Young Prader Willi Syndrome Patients following Clonidine Provocation for Growth Hormone

Gregory A Hollman1, David B Allen, Jens C Eickhoff

  • 1American Family Children's Hospital, Department of Pediatrics, University of Wisconsin, Madison, WI 53792, USA.

Insights

Clonidine used for growth hormone (GH) testing in children with Prader Willi Syndrome (PWS) caused significant sedation and respiratory depression. Doses often exceeded those for sedation, leading to concerning effects in some patients.

Area of Science:

  • Pediatric Endocrinology
  • Pharmacology
  • Genetics

Background:

  • Prader Willi Syndrome (PWS) is a complex genetic disorder affecting multiple body systems.
  • Growth hormone (GH) deficiency is common in PWS, necessitating accurate assessment.
  • Clonidine is sometimes used to stimulate GH secretion, but its safety profile in PWS requires evaluation.

Purpose of the Study:

  • To assess the sedative and respiratory effects of clonidine when administered for growth hormone (GH) secretion evaluation in children with Prader Willi Syndrome (PWS).

Main Methods:

  • A prospective study involving 17 children with PWS, undergoing up to four clonidine challenge tests over three years.
  • Clonidine was administered at a dose of 0.15 mg/m(2).
  • Vital signs, oxygen saturation, and sedation levels were meticulously recorded at baseline and every five minutes post-administration.

Main Results:

  • All 60 studies resulted in sedation scores of 4-5 (drowsy to asleep).
  • Significant mean declines in respiratory rate (7.5 breaths/min) and oxygen saturation (2.2%) were observed (P < .001).
  • Nine instances of oxygen saturation ≤94% occurred in five patients (29%), with three linked to partial airway obstruction.

Conclusions:

  • Clonidine doses used for GH assessment in PWS frequently surpass typical sedation doses.
  • These higher doses can lead to considerable respiratory depression and oxygen desaturation in some children with PWS.
  • No correlation was found between oxygen desaturation and Body Mass Index (BMI) in this cohort.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...